ATHA
Price
$3.83
Change
+$0.05 (+1.32%)
Updated
Sep 18 closing price
Capitalization
15.11M
48 days until earnings call
NTLA
Price
$16.11
Change
+$3.70 (+29.81%)
Updated
Sep 18 closing price
Capitalization
1.73B
48 days until earnings call
Interact to see
Advertisement

ATHA vs NTLA

Header iconATHA vs NTLA Comparison
Open Charts ATHA vs NTLABanner chart's image
Athira Pharma
Price$3.83
Change+$0.05 (+1.32%)
Volume$100.12K
Capitalization15.11M
Intellia Therapeutics
Price$16.11
Change+$3.70 (+29.81%)
Volume$16.5M
Capitalization1.73B
ATHA vs NTLA Comparison Chart in %
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. NTLA commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (ATHA: $3.83 vs. NTLA: $16.11)
Brand notoriety: ATHA and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 529% vs. NTLA: 335%
Market capitalization -- ATHA: $15.11M vs. NTLA: $1.73B
ATHA [@Biotechnology] is valued at $15.11M. NTLA’s [@Biotechnology] market capitalization is $1.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • ATHA’s TA Score: 4 bullish, 7 bearish.
  • NTLA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than ATHA.

Price Growth

ATHA (@Biotechnology) experienced а +0.24% price change this week, while NTLA (@Biotechnology) price change was +41.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +38.54%.

Reported Earning Dates

ATHA is expected to report earnings on Nov 06, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.73B) has a higher market cap than ATHA($15.1M). NTLA YTD gains are higher at: 38.165 vs. ATHA (-34.720). ATHA has higher annual earnings (EBITDA): -56.92M vs. NTLA (-501.87M). ATHA has less debt than NTLA: ATHA (1.02M) vs NTLA (103M). NTLA has higher revenues than ATHA: NTLA (52.9M) vs ATHA (0).
ATHANTLAATHA / NTLA
Capitalization15.1M1.73B1%
EBITDA-56.92M-501.87M11%
Gain YTD-34.72038.165-91%
P/E RatioN/AN/A-
Revenue052.9M-
Total CashN/A460M-
Total Debt1.02M103M1%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHANTLA
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 25 days ago
82%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VPKIX16.89N/A
N/A
Vanguard Pacific Stock Index Instl
CGRWX34.15N/A
N/A
Invesco Comstock Select A
PLLAX28.26N/A
N/A
Principal SmallCap A
NWHLX11.53N/A
N/A
Nationwide Bailard Intl Eqs M
KNGAX11.68-0.02
-0.17%
Vest S&P500 Div Aristocrats Trgt Inc A